Evaxion A (EVAX) Invested Capital (2019 - 2025)
Evaxion A's (EVAX) quarterly Invested Capital came in at $7.7 million in Q4 2025, down 25.19% YoY from $10.2 million in Q4 2024, and down 16.85% on a QoQ basis from $9.2 million in Q2 2025.
Evaxion A (EVAX) Invested Capital (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Invested Capital data on file, last reported at $7.7 million in Q4 2025.
- Quarterly Invested Capital fell 25.19% year-over-year to $7.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $16.9 million (down 9.56% YoY) and the FY2025 annual result came in at $7.7 million, down 25.19% from the prior year.
- Invested Capital retreated to $7.7 million in Q4 2025, from $9.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $11.0 million in Q4 2023 to a low of $119000.0 in Q2 2022.
- A 5-year average of $5.6 million and a median of $7.7 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2021 — Invested Capital jumped 19115.0% — and 2025, when it dropped 25.19%.
- Tracing EVAX's Invested Capital over 5 years: stood at $3.8 million in 2021, then surged by 170.6% to $10.4 million in 2022, then rose by 5.96% to $11.0 million in 2023, then decreased by 7.05% to $10.2 million in 2024, then slipped by 25.19% to $7.7 million in 2025.
- The last three Invested Capital figures came in at $7.7 million (Q4 2025), $9.2 million (Q2 2025), and $10.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.66 Mn |
| Jun 30, 2025 | 9.22 Mn |
| Dec 31, 2024 | 10.24 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Dec 31, 2023 | 11.02 Mn |
| Jun 30, 2023 | 152,000.00 |
| Dec 31, 2022 | 10.40 Mn |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 3.84 Mn |
| Sep 30, 2021 | 159,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 36,000.00 |